BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 8602842)

  • 1. The tumor suppressor gene product APC is hyperphosphorylated during the M phase.
    Bhattacharjee RN; Hamada F; Toyoshima K; Akiyama T
    Biochem Biophys Res Commun; 1996 Mar; 220(1):192-5. PubMed ID: 8602842
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The APC gene].
    Akiyama T
    Nihon Rinsho; 1996 Apr; 54(4):955-9. PubMed ID: 8920656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Variations in the expression of the adenomatous polyposis coli (APC) tumor suppressor gene in human cancer cell lines of different tissue origin.
    Dihlmann S; Amler LC; Schwab M; Wenzel A
    Oncol Res; 1997; 9(3):119-27. PubMed ID: 9220497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GSK-3beta-dependent phosphorylation of adenomatous polyposis coli gene product can be modulated by beta-catenin and protein phosphatase 2A complexed with Axin.
    Ikeda S; Kishida M; Matsuura Y; Usui H; Kikuchi A
    Oncogene; 2000 Jan; 19(4):537-45. PubMed ID: 10698523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphorylation of the adenomatous polyposis coli protein and its possible regulatory effects in cells.
    Bhattacharya G; Boman BM
    Biochem Biophys Res Commun; 1995 Mar; 208(1):103-10. PubMed ID: 7887918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Adenomatous Polyposis Coli-protein (APC) interacts with the protein tyrosine phosphatase PTP-BL via an alternatively spliced PDZ domain.
    Erdmann KS; Kuhlmann J; Lessmann V; Herrmann L; Eulenburg V; Müller O; Heumann R
    Oncogene; 2000 Aug; 19(34):3894-901. PubMed ID: 10951583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The APC gene product and colorectal carcinogenesis.
    Bonneton C; Larue L; Thiéry JP
    C R Acad Sci III; 1996 Oct; 319(10):861-9. PubMed ID: 8977766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nuclear accumulation of full-length and truncated adenomatous polyposis coli protein in tumor cells depends on proliferation.
    Fagman H; Larsson F; Arvidsson Y; Meuller J; Nordling M; Martinsson T; Helmbrecht K; Brabant G; Nilsson M
    Oncogene; 2003 Sep; 22(38):6013-22. PubMed ID: 12955080
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation and function of the interaction between the APC tumour suppressor protein and EB1.
    Askham JM; Moncur P; Markham AF; Morrison EE
    Oncogene; 2000 Apr; 19(15):1950-8. PubMed ID: 10773885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Familial adenomatous polyposis syndrome (FAP): pathogenesis and molecular mechanisms].
    Friedrich A; Kullmann F
    Med Klin (Munich); 2003 Dec; 98(12):776-82. PubMed ID: 14685680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The beta-catenin binding domain of adenomatous polyposis coli is sufficient for tumor suppression.
    Shih IM; Yu J; He TC; Vogelstein B; Kinzler KW
    Cancer Res; 2000 Mar; 60(6):1671-6. PubMed ID: 10749138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aberrant methylation of the adenomatous polyposis coli (APC) gene promoter 1A in breast and lung carcinomas.
    Virmani AK; Rathi A; Sathyanarayana UG; Padar A; Huang CX; Cunnigham HT; Farinas AJ; Milchgrub S; Euhus DM; Gilcrease M; Herman J; Minna JD; Gazdar AF
    Clin Cancer Res; 2001 Jul; 7(7):1998-2004. PubMed ID: 11448917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased beta-catenin protein and somatic APC mutations in sporadic aggressive fibromatoses (desmoid tumors).
    Alman BA; Li C; Pajerski ME; Diaz-Cano S; Wolfe HJ
    Am J Pathol; 1997 Aug; 151(2):329-34. PubMed ID: 9250146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association and regulation of casein kinase 2 activity by adenomatous polyposis coli protein.
    Homma MK; Li D; Krebs EG; Yuasa Y; Homma Y
    Proc Natl Acad Sci U S A; 2002 Apr; 99(9):5959-64. PubMed ID: 11972058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A role for the Adenomatous Polyposis Coli protein in chromosome segregation.
    Kaplan KB; Burds AA; Swedlow JR; Bekir SS; Sorger PK; Näthke IS
    Nat Cell Biol; 2001 Apr; 3(4):429-32. PubMed ID: 11283619
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Purification of the adenomatous polyposis coli (APC) gene product.
    Bhattacharya G; Abraham CA; Wildrick DM; Boman BM
    Arch Biochem Biophys; 1995 Nov; 323(2):233-6. PubMed ID: 7487082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The many faces of the tumor suppressor gene APC.
    van Es JH; Giles RH; Clevers HC
    Exp Cell Res; 2001 Mar; 264(1):126-34. PubMed ID: 11237529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phosphorylation of the tumor suppressor adenomatous polyposis coli (APC) by the cyclin-dependent kinase p34.
    Trzepacz C; Lowy AM; Kordich JJ; Groden J
    J Biol Chem; 1997 Aug; 272(35):21681-4. PubMed ID: 9268294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of adenomatous polyposis coli (APC) tumor supressor gene in human colon cancer cell lines on cell cycle arrest by apigenin.
    Chung CS; Jiang Y; Cheng D; Birt DF
    Mol Carcinog; 2007 Sep; 46(9):773-82. PubMed ID: 17620292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A mammalian two-hybrid system for adenomatous polyposis coli-mutated colon cancer therapeutics.
    Wakita K; Tetsu O; McCormick F
    Cancer Res; 2001 Feb; 61(3):854-8. PubMed ID: 11221869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.